Wednesday, February 10, 2010, 1:51am EST - Canadian Markets open in 7 hours and 39 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Cytokinetics Inc. (CYTK)

 On Feb 9: 3.02 USD  Down 0.04 (1.31%)  
MORE ON CYTK
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Cytokinetics, Incorporated (NGM:CYTK) Delayed quote dataEdit
After Hours: 3.02 Up 0.00 (0.02%) as of 4:12pm EST on 02/09/10
Last Trade: 3.02 USD
Trade Time: Feb 9
Change: Down 0.04 (1.31%)
Prev Close: 3.06
Open: 3.07
Bid: 2.62 x 100
Ask: 3.23 x 200
1y Target Est: 9.90
Day's Range: 2.99 - 3.12
52wk Range: 1.39 - 5.55
Volume: 126,285
Avg Vol (3m): 346,317
Market Cap: 184.01M
P/E (ttm): 6.32
EPS (ttm): 0.48
Div & Yield: N/A (N/A%)
Cytokinetics Inc. (CYTK)
1d  5d  3m  6m  1y  2y  5y  max 
 Add CYTK to Portfolio   Download Data

HEADLINES
• New Star Analyst Rankings for Cytokinetics, Incorporated
StarMine (Thu, Feb 4)
• Cytokinetics Inc. Q4 2009 Earnings Call Transcript
at Seeking Alpha (Wed, Feb 3)
• CYTOKINETICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Wed, Feb 3)
• Cytokinetics, Incorporated Reports Fourth Quarter and Year End 2009 Financial Results
Marketwire (Wed, Feb 3)
• Q4 2009 Cytokinetics, Inc. Earnings Release - 4:00 pm ET
CCBN (Wed, Feb 3)
• Cytokinetics to Present at BIO CEO and Investor Conference
Marketwire (Mon, Feb 1)
• Cytokinetics, Inc. Earnings Call scheduled for Wed, Feb 3
CCBN (Wed, Jan 27)
• Cytokinetics to Announce Fourth Quarter and Year End Results On February 3, 2010
Marketwire (Wed, Jan 27)
• CYTOKINETICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Wed, Jan 27)
• Cytokinetics Announces Data From Phase I Multiple Dose Clinical Trial of CK-2017357
Marketwire (Wed, Jan 27)
More Headlines for CYTK...
ANALYST
EPS Est (next year) (Dec-10) : -0.81
EPS Est (in 2 years) (Dec-11) : -0.75
Avg Rec (current)*: 1.7
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Cytokinetics, Incorporated, a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule drug therapeutics for the treatment of cardiovascular diseases and cancer.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices